These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 21543469)
1. Host-based ribavirin resistance influences hepatitis C virus replication and treatment response. Ibarra KD; Jain MK; Pfeiffer JK J Virol; 2011 Jul; 85(14):7273-83. PubMed ID: 21543469 [TBL] [Abstract][Full Text] [Related]
2. Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. Ibarra KD; Pfeiffer JK J Virol; 2009 May; 83(9):4538-47. PubMed ID: 19244331 [TBL] [Abstract][Full Text] [Related]
3. Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1. Panigrahi R; Chandra PK; Ferraris P; Kurt R; Song K; Garry RF; Reiss K; Coe IR; Furihata T; Balart LA; Wu T; Dash S J Virol; 2015 Jan; 89(1):626-42. PubMed ID: 25339775 [TBL] [Abstract][Full Text] [Related]
4. Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype. Satoh S; Mori K; Ueda Y; Sejima H; Dansako H; Ikeda M; Kato N PLoS One; 2015; 10(2):e0118313. PubMed ID: 25699517 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556 [TBL] [Abstract][Full Text] [Related]
6. Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model. Galli A; Mens H; Gottwein JM; Gerstoft J; Bukh J Sci Rep; 2018 Mar; 8(1):4619. PubMed ID: 29545599 [TBL] [Abstract][Full Text] [Related]
7. Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA. Pfeiffer JK; Kirkegaard K J Virol; 2005 Feb; 79(4):2346-55. PubMed ID: 15681435 [TBL] [Abstract][Full Text] [Related]
8. Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin. Mori K; Hiraoka O; Ikeda M; Ariumi Y; Hiramoto A; Wataya Y; Kato N Hepatology; 2013 Oct; 58(4):1236-44. PubMed ID: 23532970 [TBL] [Abstract][Full Text] [Related]
9. Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin. Shah NR; Sunderland A; Grdzelishvili VZ PLoS One; 2010 Jun; 5(6):e11265. PubMed ID: 20582319 [TBL] [Abstract][Full Text] [Related]
10. Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8. Tokumoto Y; Hiasa Y; Uesugi K; Watanabe T; Mashiba T; Abe M; Kumagi T; Ikeda Y; Matsuura B; Onji M J Infect Dis; 2012 Apr; 205(7):1121-30. PubMed ID: 22357660 [TBL] [Abstract][Full Text] [Related]
11. HCV infection selectively impairs type I but not type III IFN signaling. Chandra PK; Bao L; Song K; Aboulnasr FM; Baker DP; Shores N; Wimley WC; Liu S; Hagedorn CH; Fuchs SY; Wu T; Balart LA; Dash S Am J Pathol; 2014 Jan; 184(1):214-29. PubMed ID: 24215913 [TBL] [Abstract][Full Text] [Related]
12. ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system. Iikura M; Furihata T; Mizuguchi M; Nagai M; Ikeda M; Kato N; Tsubota A; Chiba K Antimicrob Agents Chemother; 2012 Mar; 56(3):1407-13. PubMed ID: 22232287 [TBL] [Abstract][Full Text] [Related]
13. Ribavirin-induced mutagenesis across the complete open reading frame of hepatitis C virus genotypes 1a and 3a. Mejer N; Fahnøe U; Galli A; Ramirez S; Benfield T; Bukh J J Gen Virol; 2018 Aug; 99(8):1066-1077. PubMed ID: 29927371 [TBL] [Abstract][Full Text] [Related]
14. Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin? Galmozzi E; Aghemo A; Colombo M Med Hypotheses; 2012 Oct; 79(4):471-3. PubMed ID: 22824093 [TBL] [Abstract][Full Text] [Related]
15. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes. Testoni B; Durantel D; Lebossé F; Fresquet J; Helle F; Negro F; Donato MF; Levrero M; Zoulim F Gut; 2016 Apr; 65(4):672-82. PubMed ID: 26082258 [TBL] [Abstract][Full Text] [Related]
16. Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy. Saito Y; Imamura M; Uchida T; Osawa M; Teraoka Y; Fujino H; Nakahara T; Ono A; Murakami E; Kawaoka T; Miki D; Tsuge M; Serikawa M; Aikata H; Abe-Chayama H; Hayes CN; Chayama K J Med Virol; 2020 Feb; 92(2):210-218. PubMed ID: 31584207 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection. Di Bisceglie AM; Janczweska-Kazek E; Habersetzer F; Mazur W; Stanciu C; Carreno V; Tanasescu C; Flisiak R; Romero-Gomez M; Fich A; Bataille V; Toh ML; Hennequi M; Zerr P; Honnet G; Inchauspé G; Agathon D; Limacher JM; Wedemeyer H Gastroenterology; 2014 Jul; 147(1):119-131.e3. PubMed ID: 24657484 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication. Chou WW; Huang CF; Yeh ML; Tsai YS; Hsieh MY; Huang CI; Huang JF; Tsai PC; Hsi E; Juo SH; Tsai WL; Chuang WL; Yu ML; Dai CY J Mol Med (Berl); 2016 Mar; 94(3):311-20. PubMed ID: 26489607 [TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis C virus recurrence after transplantation with sofosbuvir/ledipasvir: The role of ribavirin. Globke B; Raschzok N; Teegen EM; Pratschke J; Schott E; Eurich D Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943544 [TBL] [Abstract][Full Text] [Related]
20. Effect of ribavirin and interferon beta on miRNA profile in the hepatitis C virus subgenomic replicon-bearing Huh7 cells. Gong BD; Xie Q; Xiang XG; Wang L; Zhao GD; An FM; Wang H; Lin LY; Yu H; Bao SS Int J Mol Med; 2010 Jun; 25(6):853-9. PubMed ID: 20428788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]